20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 17.65% year over year to ($0.20), which beat the estimate of ($0.29).
Revenue of $12,560,000 rose by 41.36% from the same period last year, which beat the estimate of $11,800,000.
Guidance
The upcoming fiscal year's revenue expected to be between $53,000,000 and $54,000,000.
How To Listen To The Conference Call
Date: Aug 10, 2021
Time: 08:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/4vp62jd3
Price Action
52-week high: $28.90
52-week low: $17.01
Price action over last quarter: down 17.60%
Company Profile
Itamar Medical Ltd engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardiological conditions and sleeps breathing disorders. It offers medical devices based on the Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides a WatchPAT device, a mobile device for convenient home use in the diagnoses of sleep breathing disorders; and an EndoPAT device that diagnoses endothelial dysfunction. Geographically, it derives a majority of revenue from the United States and Canada.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!